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Abstract: The anxiolytic and antidepressant-like activities of the naturally occurring monoterpene
1,8-cineole and its structural isomer 1,4-cineole were evaluated in mice via inhalation administration
at doses ranging from 4 × 10−6 to 4 × 10−1 mg per 400 µL of triethyl citrate. Mice were tested for
anxiety-like behaviours by using the light–dark box test (LDB) and marble-burying test (MBT) and
for depression-like symptoms by using the forced swimming test (FST) and tail suspension test
(TST). Diazepam and fluoxetine were used as standard drugs for anxiolytic and antidepressant
tests, respectively. The results showed that 1,8-cineole at 4 × 10−4 mg, and 1,4-cineole at 4 × 10−4
and 4 × 10−3 mg significantly increased the amount of time spent in the light box and the number
of entries in the light box in the LDB as well as reduced the number of marbles buried in the
MBT relative to those in the control, suggesting an anxiolytic effect. Similarly, 1,8-cineole at
4 × 10−4 and 4 × 10−2 mg and 1,4-cineole at doses of 4 × 10−4 to 4 × 10−2 mg significantly reduced
immobility times in the FST and TST relative to those of the control, suggesting an antidepressant
activity. The role of the GABAA/benzodiazepine receptor system in the anxiolytic effects of 1,8- and
1,4-cineole was investigated through co-administration of flumazenil, a GABAergic system antagonist.
Flumazenil reversed the effects of diazepam and 1,8-cineole, suggesting that 1,8-cineole affects the
GABAA/benzodiazepine receptors. Collectively, the results suggest that inhaled 1,8- and 1,4-cineole
prevented anxiety and depressive-like symptoms in classic mice models.
Keywords: cineole; anxiety; depression; light-dark box test; marble-burying test; forced swimming
test; tail suspension test
1. Introduction
Anxiety is one of the most common mental illnesses and affects more than one-eighth of the adult
population worldwide [1]. A pharmacotherapeutic approach is typically used to treat anxiety, but these
therapies are associated with several side effects, such as memory disturbance, interactions with other
drugs, and dependence. Another important psychiatric condition is depression, with a substantial
morbidity and high suicide rate. The medicines currently used to treat depression often demonstrate
shortcomings, such as slow onset of action, low response rates, and drug resistance development,
which limits their utilisation. For many years, anxiety and depression were considered to be separate
pathologies, but presently, the use of benzodiazepines for the treatment of anxiety only is being slowly
replaced with antidepressants that can treat depression and major anxiety disorders [2]. Aside from
their side effects and limited utilisation, these medicines contribute to a high economic burden of
disease and are long-term or life-long treatments. Considering these limitations, there is a need for
novel psychopharmacological approaches that are efficient with fewer side effects. Recently, natural
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products have been considered to be promising for the treatment of anxiety and depression, and several
studies have investigated essential oils from plant materials because they have demonstrated excellent
results in the central nervous system (CNS), such as an anxiolytic, relaxant, sedative, antinociceptive or
antidepressant effects [3–5].
Eucalyptol, which is 1,8-cineole or 1,3,3-trimethyl-2-oxabicyclo [2.2.2] octane (Figure 1a), is a
monoterpene ether present in essential oils derived from many plants, such as eucalyptus and
rosemary. Various pharmacological activities, such as sedative, antihypertensive, anti-inflammatory
and antinociceptive effects, of 1,8-cineole have been demonstrated [6–8]. A minor component of
plant extracts containing 1,8-cineole that is found in cardamom and Piper cubeba is 1,4-cineole or
1-methyl-4-propan-2-yl-7-oxabicyclo[2.2.1] heptane (Figure 1b), a natural monoterpene stereoisomer of
1,8-cineole, which has also exhibited interesting bioactivity, such as an anxiolytic-like action in mice via
oral administration, and has been shown to be a precursor for microbial hydroxylation [9,10].
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test (LDB) and marble-burying test (MBT), studied the possible involvement of the GABAergic 
transmission system in the anxiolytic activities of 1,8- and 1,4-cineole by using flumazenil (FLU; an 
antagonist of the GABAergic transmission system), evaluated the antidepressant activities of 1,8- and 
1,4-cineole by using the forced swimming test (FST) and tail suspension test (TST), which are mice 
models of depression, and assessed any possible deficit in neuromuscular function that could bias 
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2. Results and Discussion 
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specific test for measuring behavioural and physiological responses. In all experiments, the mice were
administered inhalation doses ranging from 4 × 10−6 to 4 × 10−1 mg 1,8- or 1,4-cineole dissolved in
400 µL of triethyl citrate (TEC) individually on the basis of previous experiments [3,14,19].
2.1. Anxiolytic-Like Activities of 1,8- and 1,4-cineole by Using the LDB
The LDB is considered to be one of the most widely validated tests for assaying the activities of
anxiolytic agents. Reportedly, in the LDB, anxiolytic drugs tend to increase the number of entries in
the light box (NELB) and the time spent in the light box (TSLB) [20]. Our results show that diazepam
0.5 mg/kg i.p., used as a positive control, significantly increased TSLB and NELB by 84% and 57%,
respectively, relative to the levels in the vehicle (saline) group. A dose of 1,8-cineole 4 × 10−4 mg
significantly increased TSLB by 75% relative to the level in the control group (F (11,108) = 14.79,
p < 0.001) (Figure 2a); however, it was decreased by 20% relative to that after dosing with diazepam.
Similarly, 4 × 10−4 mg 1,8-cineole significantly increased NELB by 40% relative to the level in the
control group (F (11,108) = 13.37, p < 0.001) (Figure 2b), but decreased it by 17% relative to the level
when using diazepam. These results validated the experiment and suggested an anxiolytic-like activity
of 1,8-cineole slightly inferior to that of diazepam.
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Figure 2. The light–dark box test (LDB) of ice treated with 1,8- (a,b) or 1,4-cineole (c,d) (4 × 10−6
to 4 × 10−1 mg), diazepam (0.5 mg/kg) or flumazenil (2.5 mg/kg). The parameters analysed were
the time spent in the light box (TSLB) (a,c) and the number of entries in the light box (NELB) (b,d).
The values are given as the mean ± SEM of 10 mice. The letter “a” indicates a significant difference when
compared with the control (TEC—triethyl citrate); the letter “b” indicates a significant difference when
compared with the vehicle (saline); the letter “c” indicates a significant difference when compared with
diazepam; the letter “d” indicates a significant difference when compared with 1,8-cineole 4 × 10−4 mg
or 1,4-cineol 4 × 10−3 mg. Statistical differences v . the control group were calculated by using
Student’s t test or one-way analysis of variance (ANOVA) followed by Dunnett’s test. (* p < 0.05,
** p < 0.01, *** p < 0.001).
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Our findings are supported by the study of Kim et al. [21], who showed that inhaled 1,8-cineole,
significantly reduced preoperative anxiety in humans. Similarly, administration of the essential oil
from Achillea wilhelmsii C. Koch, which contains 1,8-cineole as a major compound (20.8%), showed
anxiolytic activity [4].
We found that 1,4-cineole at doses of 4 × 10−4 and 4 × 10−3 mg significantly increased TSLB by
60% and 182%, respectively (F (11,108) = 38.20, p < 0.001) (Figure 2c), and significantly increased
NELB by 83% and 110%, respectively, relative to the levels in the control (F (11,108) = 13.11, p < 0.001)
(Figure 2d). Additionally, the effect of 1,4-cineole 4 × 10−3 mg was better than that of 4 × 10−4 mg
in both TSLB and NELB and 23% greater than that of diazepam. These results indicate a potential
anxiolytic effect of 1,4-cineole. Our inhalation administration of 1,4-cineole showed results similar to
those of Gomes et al. [9], who demonstrated that the oral administration of 1,4-cineole 400 mg/kg had
anxiolytic activity in mice. These results suggested that 1,8- and 1,4-cineole could be used as anxiolytic
agents depending on the dose and route of administration.
2.2. The Role of the GABAA/Benzodiazepine Receptor System in the Anxiolytic Activity of 1,8- and 1,4-cineole
Several mechanisms have been proposed to explain anxiety and depression symptoms, and
studies have frequently reported mediation via the GABAergic transmission system [5,22,23]. GABA
is the primary inhibitory neurotransmitter in the CNS, and it has been reported that one third of all
CNS neurons are thought to be mediated via the GABAergic transmission system [23]. Therefore, we
investigated the implication of the GABAergic system transmission in the anxiolytic activity of 1,8-
and 1,4-cineole. FLU 2.5 mg/kg i.p., an antagonist of benzodiazepine drugs, was administered together
with 1,8-cineole 4 × 10−4 mg and 1,4-cineole 4 × 10−3 mg in the LDB. During the tests with 1,8-cineole,
FLU alone did not alter TSLB and NELB (Figure 2a,b, respectively). However, the pre-treatment of
FLU with diazepam significantly reduced TSLB by 45% (F (11,108) = 16.79, p < 0.001) (Figure 2a) and
NELB by 34% (F (11,108) = 13.37, p < 0.001) (Figure 2b) relative to the tests with diazepam alone. These
results confirmed the antagonistic effect of FLU on diazepam. Similarly, the treatment of 1,8-cineole
4 × 10−4 mg with FLU significantly reduced TSLB and NELB by 38% and 34%, respectively, relative
to the tests with 1,8-cineole 4 × 10−4 mg (Figure 2a,b), suggesting an antagonistic effect of FLU on
1,8-cineole. Some authors have previously suggested that 1,8-cineole may exert its activity through the
GABAergic transmission system [15,24].
During the tests with 1,4-cineole, the FLU, diazepam, and diazepam + FLU groups showed similar
results to those of the tests with 1,8-cineole, which validated the experiments. However, in both TSLB
and NELB, the anxiolytic effect of 1,4-cineole 4 × 10−3 mg was not reversed by co-administration
with FLU (Figure 2c,d), indicating that the anxiolytic effect of 1,4-cineole was not mediated via
GABAA/benzodiazepine receptors. These results are consistent with those of Gomes et al. [9], who
found that 1,4-cineole administered orally to mice did not involve benzodiazepine receptors. Further
investigations on 1,4-cineole need to be conducted in future experiments to elucidate the possible role
of 5-HT1A, D1 or noradrenergic receptors in the anxiolytic activity.
2.3. Anxiolytic-Like Activities of 1,8- and 1,4-cineole by Using the MBT
To further corroborate the anxiolytic activity observed in the LDB, we also performed the MBT
in which rodents tend to bury glass marbles. This behaviour is interpreted as related to anxiety;
consequently, anxiolytic drugs tend to reduce the number of marbles buried (NMB) [13]. Results
similar to those of the LDB were observed for both 1,8- and 1,4-cineole in the MBT. When compared
with the NMB of the control, that of the mice treated with 1,8-cineole 4 × 10−4 mg was reduced by
26% (F (8,81) = 5.297, p < 0.001), which indicated an anxiolytic-like effect of 1,8-cineole (Figure 3a).
The NMBs of the mice treated with 1,4-cineole at doses of 4 × 10−4 and 4 × 10−3 mg were reduced
by 29% and 38%, respectively (F (8,81) = 6.431, p < 0.001), relative to those of the control (Figure 3b),
indicating an anxiolytic-like activity of 1,4-cineole.
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using Student’s t test or ANOVA followed by Dunnett’s test. (* p < 0.05, ** p < 0.01, *** p < 0.001).
Moreover, 1,4-cineole 4 × 10−3 mg had a superior a xiolytic-l ke effect to that of 1,4-cineole
4 × 10−4 mg and was greater than that of diazepam, as observed in the LDB. Similar to 1,8- and
1,4-cineole, other monoterpenes and derivatives of monoterpenes have been demonstrated to possess
anxiolytic-like activity, such as that shown by epoxy–limonene administered at 25, 50 and 75 mg/kg i.p.
in Swiss mice [13] and of carvacryl acetate administered at 50 and 75 mg/kg i.p. in mice [16], which
demonstrated good anxiolytic activit es relative to those of the vehicle.
2.4. Sedative Effects of 1,8- and 1,4-cineole by Using the OFT
To further investigate the effects of 1,8- and 1,4-cineole on the CNS, we explored the sedative
activity of 1,4-cineole in the OFT. The OFT utilises behavioural changes in rodents exposed to a novel
environment and has been used to detect sedative activity in mice [3,14,19,25–27]. Mice administered
1,4-cineole at doses ranging from 4 × 10−6 to 4 × 10−1 mg p r 400 µL of TEC sh wed a decrease
in locomotor activity at all dos s. As shown in Figure 4a, there was a significant decrease in mice
locomotor activity at doses of 1,4-cineole 4 × 10−4 and 4 × 10−2 mg by 70% and 59%, respectively
(F (7,40) = 5.236, p < 0.001), relative to those of the control. Moreover, the analysis of locomotor
activity transition (Figure 4b) showed that the sedative effects produced by the doses of 4 × 10−4 mg
and 4 × 10−2 mg 1,4-cineole were the most effective and locomotor activity dropped nearly to zero
15–20 min after inhalation administration.
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Controversially, Gomes et al. [9] showed that 1,4-cineole 100 and 200 mg/kg p.o did not induce any
change in mice locomotor activity. Differences in the results could be due to the differences in the doses
administered and routes of administration. Additionally, Gomes et al. [9] performed the OFT for 5 min,
whereas we performed it for 60 min. It has been reported that the sedative activity is observed generally
20–30 min after drug administration [3,14,19,25–27]. Moreover, Gomes et al. [9] concluded that a higher
dose of 1,4-cineole could demonstrate sedative activity because their pentobarbital test indicated a
possible sedative effect for 1,4-cineole. The sedative effect of 1,8-cineole was studied in our previous
study [6] and it showed a significant decrease in locomotor activity at 4 × 10−4 mg. Taken together,
our results observed in the LDB, MBT and OFT suggest that 1,8- and 1,4-cineole exhibit anxiolytic
effects associated with sedative action in mice. Similar to the activity in 1,8- and 1,4-cineole, anxiolytic
activity has been often associated with sedative effects in other terpenoids, such as linalool, nerol,
limonene epoxide, and thymol and in essential oils from Ocimum gratissimum L., Telfairia occidentalis,
Piper guineense, and Citrus aurantium L. [3,13,14,17,18,28,29].
2.5. Evaluation of a Possible Peripheral Neuromuscular Blockage by Using the HWT
A deficit in motor coordination would likely affect the performance of the mice in the OFT.
Therefore, we investigated the effects of 1,8- and 1,4-cineole in the HWT, a classic animal model used
to evaluate peripheral neuromuscular blockage. Our findings show that diazepam 5 mg/kg i.p. as a
positive control significantly decreased the percentage of mice grasping the wire by 60% and 50% in the
tests with 1,8- and 1,4-cineole, respectively, relative to the levels in the control (Figure 5a,b), indicating
a myorelaxant effect of diazepam.
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4 × 10−1 mg) or diazepam (5 mg/kg). The values re given as the mean ± SEM of 10 mice. Statistical
differ nces vs. the control gro p were calculated by using Student’s t test or ANOVA followed by
Dunnett’s test. (** p < 0.01).
In contrast, no change was observed after treatment with 1,8- or 1,4-cineole at doses ranging
from 4 × 10−6 to 4 × 10−1 mg per 400 µL of TEC relative to the levels in the control, indicating a lack
of myorelaxation effect at these doses. Consequently, the observed decrease in locomotor activity
is probably not related to peripheral neuromuscular blockage but may involve neurons that control
CNS activity. Similar results were obtained for the methyl and isopropyl N-methylanthranilates from
Choisya ternata and for quercetin [23,30]. The LD50 value for oral administration of 1,8-cineole in mice
is 3849 mg/kg [31], whereas the LD50 value for 1,4-cineole is 3100 mg/kg in rats [32]. The maximum
administered dose in our study was 4 × 10−1 mg, which is much lower than the toxic doses. Moreover,
abnormalities, such as an increase in urination or defecation, twisting, tremors, seizures, catalepsy and
stereotypical behaviours, were not noticed, suggesting that the effect is probably not toxic.
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2.6. Antidepressant-Like Activities of 1,8- and 1,4-cineole by Using the FST and TST
In addition to the anxiolytic-like activities, we investigated 1,8- and 1,4-cineole, for their activity
in the most widely used animal models for antidepressant drug screening, the FST [33] and TST [34].
In these tests, mice are forced to swim or are hung by their tails in an inescapable situation; the mice
first demonstrate vigorous activity trying to escape the threatening environment and finally become
immobile as a symptom of behavioural despair. Substances that decrease immobility time are known
to demonstrate antidepressant properties in humans. In the FST, 1,8-cineole at doses of 4 × 10−4 and
4 × 10−2 mg induced a significant decrease in the immobility time of mice by 44% and 39%, respectively,
relative to the times in the control group (F (8,81) = 5.400, p < 0.001) (Figure 6a).
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4 × g) or fluoxetine (20 mg/kg). The param ter analysed was i mobility time in each test. The
values are given as the mean ± SE f e le ter “a” indicates a significant diff rence when
compared with the control (TEC); the l tt i icates a significant difference when compared with
the vehicle (saline). Statistic l iff r c s s. the control group w re calculated by using Student’s
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Treatment with t e antidepressant drug fluoxetine (FLX) at 20 mg/kg p.o., used as a positive control,
also significantly reduced the immobility ti e by 40% relative to the time in the vehicle (saline) group.
Additionally, 1,8-cineole at doses of 4 × 10−4 and 4 × 10−2 mg had greater antidepressant effects by 21%
and 13%, respectively, relative to those for FLX. Antidepressant effects were previously observed in
mice after the oral administration of R. officinalis containing 45% 1,8-cineole [35]. On the other hand,
no antidepressant activity was detected for 1,8-cineole 1 mg/kg administered intraperitoneally [15];
however, the authors suggested that the single-dose regimen of 1,8-cineole 1 mg/kg i.p. could be
insufficient to potentially produce an antidepressant effect. As shown in Figure 6b, 1,4-cineole at doses
of 4 × 10−4 to 4 × 10−2 mg induced dose-dependent significant decreases in the immobility times of mice
by 46%, 49% and 56%, respectively, relative to those in the control group (F (8,81) = 10.60, p < 0.001).
Compared with the effect of FLX, the effects of 1,4-cineole at doses of 4 × 10−4 to 4 × 10−2 mg were 24%,
29% and 39% greater, indicating the potent antidepressant activity of 1,4-cineole. In contrast to our
study, Gomes et al. [9] found possible depressive activity of 1,4-cineole 400 mg/kg p.o. The differences in
the results could also be explained by differences in the administered doses and routes of administration.
Sousa et al. [36] made the same observations, suggesting that the administration route or difference in
ex eri ental models could explain differences in the pharmacological effects.
In the TST, as shown in Figure 7a, similar to the results observed in the FST, 1,8-cineole at doses
of 4 × 10−4 and 4 × 10−2 mg significantly reduced the immobility times in mice by 62% and 55%,
respectively, relative to those in the control group (F (8,81) = 7.563, p < 0.001).
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oxygen atom affected the activity of 4-phenyl-2-butanol. Another study also demonstrated that cis-
isomers were 10-fold more potent than trans-isomers of compounds [26]. Regarding 1,8- and 1,4-
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Figure 7b sho s that 1,4-cineole at doses of 4 × 10−4 to 4 × 10−2 mg significantly decreased
the immobility times in mice by 45 , 49% and 62%, respectively, relative to those of the control
group (F (8,81) = 9.290, p < 0.001). The TST for 1,8- and 1,4-cineoles showed results similar to
those of the FST, confirming the validity of our experiments. Similar to the activities of 1,8- and
1,4-cineole, antidepressant activity was previously demonstrated for terpinen-4-ol contained in
Origanum majorana [37], beta-pinene and linalool (principal constituents of Litsea glaucescens [38]), and
for the essential oil of Rosmarinus officinalis [35].
2.7. Relationship Structure-Activity of 1,8- and 1,4-cineole
The two cineole isomers investigated in the present study have identical molecular weights
(MW = 154.25 g/mol) and molecular formulas (C10H18O) but they differ in the position of the oxygen
bridge connecting atoms 1 and 4 in 1,4-cineole or atoms 1 and 8 in 1,8-cineole. However, despite
the structural similarity, their biological actions and mechanisms were different, which makes it
interesting to compare the possible relationships between their physical and biochemical characteristics
and their activities. The position of a functional group in a compound is reported to likely have
activation or inhibitory effects on their activity. In this way, the study of Miyoshi et al. [25] on
benzylacetone and derivatives demonstrated that a series of benzylacetone isomers differing only
in the position of the ketone group showed different sedative activity levels, with the most sedative
isomers being compounds with a ketone group on the carbon adjacent to C3. Additionally, aromatic
compounds with isomeric structures have previously demonstrated various effects via the activation of
the olfactory bulb [39]. The boiling point of 1,8-cineole is 176–177 ◦C, which is higher than 172–174 ◦C
for 1,4-cineole. Compounds with higher boiling points often have reduced vaporisation that may
contribute to weakening of behavioural activity, which could explain the greater activity of 1,4-cineole
than that of 1,8-cineole. Differences in conformation can also affect the activity of compounds.
Miyoshi et al. [25] demonstrated that different steric configurations of the oxygen atom affected the
activity of 4-phenyl-2-butanol. Another study also demonstrated that cis-isomers were 10-fold more
potent than trans-isomers of compounds [26]. Regarding 1,8- and 1,4-cineole, the spatial orientation of
the dimethyl side chain differed between the two molecules, as shown in Figure 8.
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In 1,4-cineole, the dimethyl group is free and located far from the hexyl ring, whereas in 1,8-cineole,
the dimethyl group is involved in the formation of a heterocyclic ring [40]. This difference made
1,4-cineole a more flexible structure with a freely rotating dimethyl group that can interact with
several types of olfactory receptors. Therefore, the differences in structural, biochemical and physical
properties could explain the differences in the behavioural activities of 1,8- and 1,4-cineole.
3. Materials and Methods
3.1. Chemical and Reagents
Triethyl citrate (purity > 98%, Merck, Kenilworth, NJ, USA), a non-sedating odourless solvent, was
used to disso ve the fragrant components. Benzylacetone (purity > 95%, Tokyo Chemical Industri s,
Ltd., Tokyo, Japan), flumazenil (purity > 98%, Wako Pure Chemical Industries, Ltd., Osaka, Japan),
diazepam (purity > 98%, Wako Pure Chemical Industries, Ltd., Osaka, Japan) and fluoxetine (purity
> 98%, Tokyo Chemical Industries, Ltd., Tokyo, Japan) w re used as positive controls. 1,4-Ci eole
(p rity > 85%) was obtained from Acros Organics (New Jersey, NJ, US). 1,8-Ci eol (purity > 85%) was
purchased from Wako P re Chemical Industries, Ltd., Osaka, Japan. All chemicals used were of the
high st grade available.
3.2. Experimental Animals
Four-week-old male ddY mice (20–30 g) were purchased from Japan SLC (Shizuoka, Japan).
The animals w re housed in colony cages under a 12 h/12 h light/dark cycle at 25 ± 2 ◦C and a relative
humidity of 50–60%. They were fed p llet chow and water ad libitum and allowed to accommodate to
t ese conditions for 1 we k before the xperiments. Animal experiments were con ucted following
the recommendations of the Animal Res arch Committee of Kyoto Univ rsity, Kyoto, Japan (approval
numb r, 2014-14-3; fir t approved 27 December 2014 and renewed annually until 14 March 2018).
Ex erimental procedures involving animals and th ir ca e were conducted in accordance with the
institutional guidelines and in compliance with the Fu amental Guidelines for the Proper Conduct of
Animal Experiments and R lated Activities in Academic Research Institutions under the jurisdiction
of the Ministry of Education, Culture, Sports, Science and Technology, Japan (2006). All experiments
we e conducted b tween 10:00 and 17:00 under identical conditions.
3.3. Behavioural Experiments
Anxiety symptoms were evaluated by using the LDB and MBT, while depressive-like behaviours
were investigated by using the FST and TST, as previously demonstrated [3,20,33,34] with minor
modifications. Inhalation administration was performed as described in the OFT. The sedative effects
and motor coordination were evaluated by using the OFT and HWT, respectively [3,30]. To avoid any
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potential bias in the experiments, each treatment group was recorded by using a video camera and
scored by a trained observer blind to the treatment. In all our experiments, each animal was used
only once.
3.3.1. Light–Dark Box Test (LDB)
The LDB is a widely used behavioural test for evaluating the anxiolytic effects of drugs. The test
is based on the innate aversion of rodents to brightly lit areas and on their spontaneous exploratory
behaviour in response to a novel environment and to light [20]. The apparatus consisted of two equally
sized compartments (30 × 30 × 34 cm each): a light area illuminated by a 60-watt desk LED lamp, and
a dark area blackened with black plastic sheets. The two compartments were separated by a black wall
with an aperture (small doorway) in its centre (5 × 5 cm) to allow passage from one compartment to
the other. In both compartments 1,8- or 1,4-cineole was charged for 60 min in accordance with the
open-field test. Thereafter, mice (n = 10/group) were individually placed in the centre of the lit area
facing the tunnel, and activity was recorded by using a video camera during a 15-min test period,
after which the number of entries in the light box (NELB) and time spent in the light box (TSLB) were
counted. Diazepam 0.5 mg/kg i.p. was used as a positive control, as previously described [3].
3.3.2. Marble-Burying Test (MBT)
The MBT is an effective method for testing the anxiolytic-like properties of a particular substance.
The test is based on the defensive burying behaviour observed in rodents in response to aversive stimuli,
such as shock; noxious food; or unanimated objects, such as glass marbles [41]. Mice (n = 10/group)
were individually introduced into the apparatus that consisted of a Plexiglas cage (42 × 34 × 15 cm)
with a floor filled with a 5-cm deep layer of sawdust and containing 20 distributed glass marbles
(15-mm diameter). Each test lasted 30 min, and a marble was considered as hidden when it was at
least two-thirds covered by sawdust. The sawdust and marbles were washed with soap and water,
cleaned with ethanol 70% and dried with a paper towel, and then the next mouse was tested.
3.3.3. Open-Field Test (OFT)
The sedative effects of 1,4-cineole on mice were evaluated using an OFT, as previously
described [3,14,19,25–27]. Administered doses were expressed as milligrams of sample per 400 µL of
TEC following previous experiments [14,25,42]. Four pieces of filter paper were placed in the four
corners of the inner walls of the glass cage (60 cm wide, 30 cm long, 34 cm high) by using adhesive tape.
On each piece of filter paper, 1,4-cineole was deposited, and the cage was closed so that the vapour
pervaded by natural diffusion. Sixty minutes after charging the sample, the mice (n = 6/group) were
individually placed in the centre of the cage and subjected to video surveillance for another 60 min.
During monitoring, the number of times a mouse crossed lines drawn at 10-cm intervals on the floor of
the cage was counted every 5 min. The area under the curve (AUC) of locomotor activity counts per
5 min (Y-axis) and time (X-axis), representing total locomotor activity, was calculated according to the
trapezoidal rule.
3.3.4. Horizontal Wire Test (HWT)
The HWT estimates motor coordination and muscle relaxation [30]. The test was performed by
treating the mice according to a slight modification of the method described by Bonetti et al. [43].
The mice were lifted by their tails and allowed to grasp a horizontally strung wire (2-mm diameter,
30-cm long) placed 25 cm above a table with their forepaws, after which they were released. The number
of mice from each treatment group (n = 10/group) that did not grasp the wire with their forepaws or
actively grasp the wire with at least one hind paw within a 10-sec period was recorded. Diazepam
(5 mg/kg, i.p.) was used as a positive control and administered 30 min before the test.
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3.3.5. Forced Swimming Test (FST)
The FST is the most widely used test for the assessment of antidepressant activity. The procedure
used is the same as previously described by Porsolt et al. [44] with some minor modifications. After
treatment with saline, fluoxetine (20 mg/kg, p.o.), TEC, or 1,8- or 1,4-cineole, the mice (n = 10/group)
were individually forced to swim in a transparent Plexiglas cylinder (40-cm high and 20-cm in diameter)
containing a 15-cm depth of water at 25 ± 2 ◦C. The water was renewed after each mouse was tested.
During the session, immobility time was recorded by using a video camera. The total duration of
immobility was measured during the last 4 min of a single 6-min test session. The mice were considered
to be immobile when they remained floating motionless or when they only made movements necessary
to keep their heads above water.
3.3.6. Tail Suspension Test (TST)
The TST is a widely used behavioural model for testing the effect of antidepressant agents. The test
was carried out by using a method described by Steru et al. [34]. Mice (n = 10/group) were individually
suspended from the edge of a suspension box (63-cm high) by an adhesive tape placed approximately
1 cm from the tip of the tail. The mice were considered to be immobile when they stopped making any
struggling movements and hung passively. The immobility time was recorded for a period of 6 min.
Fluoxetine (20 mg/kg p.o.) was administered as positive control 1 h prior to testing, to confirm the
validity of the apparatus.
3.4. Statistical Analysis
All values are expressed as the mean ± standard error of mean (SEM). Statistical analyses were
performed by using Student’s t-test or one-way analysis of variance (ANOVA) followed by Dunnett’s
multiple comparison test. GraphPad InStat software version 7 (GraphPad Software, Inc.) was used to
perform all statistical analyses. p values < 0.05 were considered to be indicative of statistical significance.
4. Conclusions
Inhalation administration is a non-harmful method of administration that can be applied to any
patient without distinction of age or mental or physical condition. This study demonstrated that 1,8-
and 1,4-cineole possessed good sedative, anxiolytic, and antidepressant activities when administered
to mice via inhalation. The study findings suggest that 1,8- and 1,4-cineole could be considered for
the treatment of CNS-related pathologies, such as post-traumatic stress disorder, attention deficit
hyperactivity disorder, insomnia, anxiety or depression.
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